ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition
Cell Reports · 2024-04 · 43 (4) · 113995
DOI: 10.1016/j.celrep.2024.113995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-04. Verfasst von Ziqi Zou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, and Department of Dermatology and Venereology of the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hang…. Hauptthemen laut MEDLINE: Arginine, Activating Transcription Factor 4, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Cancer Research UK, National Key Research and Development Program of China.
Abstract (Originalsprache)
The tumor microenvironment (TME) is restricted in metabolic nutrients including the semi-essential amino acid arginine. While complete arginine deprivation causes T cell dysfunction, it remains unclear how arginine levels fluctuate in the TME to shape T cell fates. Here, we find that the 20-μM low arginine condition, representing the levels found in the plasma of patients with cancers, confers Treg-like immunosuppressive capacities upon activated T cells. In vivo mouse tumor models and human single-cell RNA-sequencing datasets reveal positive correlations between low arginine condition and intratumoral Treg accumulation. Mechanistically, low arginine-activated T cells engage in metabolic and transcriptional reprogramming, using the ATF4-SLC7A11-GSH axis, to preserve their suppressive function. These findings improve our understanding of the role of arginine in human T cell biology with potential applications for immunotherapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, and Department of Dermatology and Venereology of the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
- MRC Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, UK.
- MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, UK; Early Cancer Institute, Department of Oncology, Hutchison Research Centre, University of Cambridge, CB…
- MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, UK.
- Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China.
- Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Förderung
- National Natural Science Foundation of China
- Cancer Research UK
- National Key Research and Development Program of China
- A.G. Leventis Foundation
- Medical Research Council
- Horizon 2020
- Wellcome Trust
- Wuhan University School of Medicine
Zitieren
APA
Zou, Z., Cheng, Q., Zhou, J., Guo, C., Hadjinicolaou, A. V., Salio, M., Liang, X., Yang, C., Du, Y., Yao, W., Wang, D., Cerundolo, V., Wang, Q., & Xia, M. (2024). ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition. Cell Reports, 43(4), 113995. https://doi.org/10.1016/j.celrep.2024.113995
Vancouver
Zou Z, Cheng Q, Zhou J, Guo C, Hadjinicolaou AV, Salio M, et al. ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition. Cell Reports. 2024;43(4):113995. doi:10.1016/j.celrep.2024.113995
BibTeX
@article{Zou2024,
author = {Zou, Ziqi and Cheng, Qian and Zhou, Jiajie and Guo, Chenyao and Hadjinicolaou, Andreas V and Salio, Mariolina and Liang, Xinghua and Yang, Cuiyu and Du, Yue and Yao, Weiran and Wang, Dongrui and Cerundolo, Vincenzo and Wang, Qingqing and Xia, Meng},
title = {ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {4},
pages = {113995},
doi = {10.1016/j.celrep.2024.113995}
}
EUVIMED